Johnson & Johnson’s psoriasis drug Tremfya has been given the green light for funding by cost-effectiveness bodies in the UK and Germany. NICE has published final guidance giving the go-ahead for funding in England after a positive final draft...
Original Article: J&J's Tremfya gets funding in Germany and UK